ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,833,180 | -4.7% | 329,274 | -9.1% | 0.02% | 0.0% |
| Q2 2023 | $32,341,160 | -12.3% | 362,366 | +1.6% | 0.02% | -17.2% |
| Q1 2023 | $36,891,462 | -12.1% | 356,637 | +3.8% | 0.03% | -14.7% |
| Q4 2022 | $41,975,348 | +18.7% | 343,694 | +0.3% | 0.03% | +9.7% |
| Q3 2022 | $35,377,000 | +11.8% | 342,600 | +0.6% | 0.03% | +19.2% |
| Q2 2022 | $31,651,000 | -23.6% | 340,486 | -3.5% | 0.03% | -7.1% |
| Q1 2022 | $41,410,000 | -4.5% | 352,846 | +9.5% | 0.03% | +3.7% |
| Q4 2021 | $43,345,000 | -1.6% | 322,198 | +16.6% | 0.03% | -10.0% |
| Q3 2021 | $44,045,000 | +28.7% | 276,333 | +6.2% | 0.03% | +30.4% |
| Q2 2021 | $34,216,000 | +33.2% | 260,103 | +30.5% | 0.02% | +21.1% |
| Q1 2021 | $25,697,000 | – | 199,383 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
| RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
| VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
| Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
| Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
| Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
| Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
| Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
| Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
| Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |